Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


14.08.2017

1 Arch Pharm (Weinheim)
1 Biochem Biophys Res Commun
1 Biomed Pharmacother
1 Biomed Res Int
1 BMC Womens Health
1 BMJ Innov
1 Br J Radiol
1 Cancer Chemother Pharmacol
1 Cancer Treat Rev
1 Cochrane Database Syst Rev
1 Eur J Cancer
1 Eur J Epidemiol
1 Eur Radiol
1 Infect Agent Cancer
1 Int J Surg Oncol
1 Int J Womens Health
1 J Cancer Educ
1 J Cell Biochem
1 J Gynecol Oncol
1 J Med Imaging Radiat Oncol
1 J Obstet Gynaecol
3 J Obstet Gynaecol Res
1 Mayo Clin Proc
3 Oncol Lett
1 Oncol Res
1 Oncologist
1 Pathol Res Pract
1 Patient Educ Couns
1 PLoS One
1 Toxicol Lett
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Pharm (Weinheim)

  1. BATRAN RZ, Dawood DH, El-Seginy SA, Ali MM, et al
    New Coumarin Derivatives as Anti-Breast and Anti-Cervical Cancer Agents Targeting VEGFR-2 and p38alpha MAPK.
    Arch Pharm (Weinheim). 2017 Aug 8. doi: 10.1002/ardp.201700064.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. LIU C, Ding L, Bai L, Chen X, et al
    Folate receptor alpha is associated with cervical carcinogenesis and regulates cervical cancer cells growth by activating ERK1/2/c-Fos/c-Jun.
    Biochem Biophys Res Commun. 2017 Aug 3. pii: S0006-291X(17)31551.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  3. WANG X, Wang Z, Wang J, Wang Y, et al
    LncRNA MEG3 has anti-activity effects of cervical cancer.
    Biomed Pharmacother. 2017;94:636-643.
    PubMed     Text format     Abstract available


    Biomed Res Int

  4. DE ROSA N, Lavitola G, Giampaolino P, Morra I, et al
    Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study.
    Biomed Res Int. 2017;2017:7513610.
    PubMed     Text format     Abstract available


    BMC Womens Health

  5. VIVIANO M, Kenfack B, Catarino R, Tincho E, et al
    Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa.
    BMC Womens Health. 2017;17:2.
    PubMed     Text format     Abstract available


    BMJ Innov

  6. TANAKA Y, Ueda Y, Okazawa A, Kakuda M, et al
    'Smartscopy' as an alternative device for cervical cancer screening: a pilot study.
    BMJ Innov. 2017;3:123-126.
    PubMed     Text format     Abstract available


    Br J Radiol

  7. KINJYO Y, Nagai Y, Toita T, Kudaka W, et al
    Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
    Br J Radiol. 2017;90:20170241.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  8. TAKEKUMA M, Mori K, Iida T, Kurihara K, et al
    The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
    Cancer Chemother Pharmacol. 2017 Aug 7. doi: 10.1007/s00280-017-3402.
    PubMed     Text format     Abstract available


    Cancer Treat Rev

  9. VENTRIGLIA J, Paciolla I, Pisano C, Cecere SC, et al
    Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.
    Cancer Treat Rev. 2017;59:109-116.
    PubMed     Text format     Abstract available


    Cochrane Database Syst Rev

  10. KOLIOPOULOS G, Nyaga VN, Santesso N, Bryant A, et al
    Cytology versus HPV testing for cervical cancer screening in the general population.
    Cochrane Database Syst Rev. 2017;8:CD008587.
    PubMed     Text format     Abstract available


    Eur J Cancer

  11. HOCKEL M, Wolf B, Hentschel B, Horn LC, et al
    Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis.
    Eur J Cancer. 2017;70:99-110.
    PubMed     Text format     Abstract available


    Eur J Epidemiol

  12. NOWAKOWSKI A, Wojciechowska U, Wieszczy P, Cybulski M, et al
    Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
    Eur J Epidemiol. 2017 Aug 5. doi: 10.1007/s10654-017-0291.
    PubMed     Text format     Abstract available


    Eur Radiol

  13. YANG W, Qiang JW, Tian HP, Chen B, et al
    Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.
    Eur Radiol. 2017 Aug 4. doi: 10.1007/s00330-017-4989.
    PubMed     Text format     Abstract available


    Infect Agent Cancer

  14. TENJIMBAYASHI Y, Onuki M, Hirose Y, Mori S, et al
    Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer.
    Infect Agent Cancer. 2017;12:44.
    PubMed     Text format     Abstract available


    Int J Surg Oncol

  15. GUBBALA K, Laios A, Madhuri TK, Pathiraja P, et al
    Results from Survey to Assess Current Trends in Surgical Practice in the Management of Women with Early Stage Cervical Cancer within the BGCS Community with an Emphasis on Routine Frozen Section Examination.
    Int J Surg Oncol. 2017;2017:2962450.
    PubMed     Text format     Abstract available


    Int J Womens Health

  16. GALLAY C, Girardet A, Viviano M, Catarino R, et al
    Cervical cancer screening in low-resource settings: a smartphone image application as an alternative to colposcopy.
    Int J Womens Health. 2017;9:455-461.
    PubMed     Text format     Abstract available


    J Cancer Educ

  17. BAZAZ M, Shahry P, Latifi SM, Araban M, et al
    Cervical Cancer Literacy in Women of Reproductive Age and Its Related Factors.
    J Cancer Educ. 2017 Aug 10. doi: 10.1007/s13187-017-1270.
    PubMed     Text format     Abstract available


    J Cell Biochem

  18. WANG J, Feng Y, Chen X, Du Z, et al
    SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion and chemoresistance to cisplatin.
    J Cell Biochem. 2017 Aug 8. doi: 10.1002/jcb.26334.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  19. YAMAGAMI W, Nagase S, Takahashi F, Ino K, et al
    Clinical statistics of gynecologic cancers in Japan.
    J Gynecol Oncol. 2017;28:e32.
    PubMed     Text format     Abstract available


    J Med Imaging Radiat Oncol

  20. VINOD SK, Lim K, Bell L, Veera J, et al
    High-risk CTV delineation for cervix brachytherapy: Application of GEC-ESTRO guidelines in Australia and New Zealand.
    J Med Imaging Radiat Oncol. 2017;61:133-140.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol

  21. CAMPBELL P, Casement M, Addley S, Dobbs S, et al
    Early catheter removal following laparoscopic radical hysterectomy for cervical cancer: assessment of a new bladder care protocol.
    J Obstet Gynaecol. 2017 Aug 6:1-3. doi: 10.1080/01443615.2017.1328668.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  22. AIKO KY, Yoko M, Saito OM, Ryoko A, et al
    Accuracy of self-collected human papillomavirus samples from Japanese women with abnormal cervical cytology.
    J Obstet Gynaecol Res. 2017;43:710-717.
    PubMed     Text format     Abstract available

  23. SUZUKI Y, Cho T, Mogami T, Yokota NR, et al
    Evaluation of endocervical curettage with conization in diagnosis of endocervical lesions.
    J Obstet Gynaecol Res. 2017;43:723-728.
    PubMed     Text format     Abstract available

  24. SUZUKI K, Furuhashi M, Kawamura T, Kubo M, et al
    Comparing Papanicolaou test results obtained during pregnancy and post-partum.
    J Obstet Gynaecol Res. 2017;43:705-709.
    PubMed     Text format     Abstract available


    Mayo Clin Proc

  25. VEGUNTA S, Files JA, Wasson MN
    Screening Women at High Risk for Cervical Cancer: Special Groups of Women Who Require More Frequent Screening.
    Mayo Clin Proc. 2017;92:1272-1277.
    PubMed     Text format     Abstract available


    Oncol Lett

  26. LIANG Y, Liu J, Liu T, Yang X, et al
    Anti-c-Met antibody bioconjugated with hollow gold nanospheres as a novel nanomaterial for targeted radiation ablation of human cervical cancer cell.
    Oncol Lett. 2017;14:2254-2260.
    PubMed     Text format     Abstract available

  27. WANG ZL, Zhou W, Xiong ZA, Yu TH, et al
    Irreversible electroporation-mediated shRNA knockdown of the HPV18 E6 gene suppresses cervical cancer growth in vitro and in vivo.
    Oncol Lett. 2017;14:1943-1949.
    PubMed     Text format     Abstract available

  28. ZHU H, Chen X, Hu Y, Shi Z, et al
    Long non-coding RNA expression profile in cervical cancer tissues.
    Oncol Lett. 2017;14:1379-1386.
    PubMed     Text format     Abstract available


    Oncol Res

  29. OU L, Wang D, Zhang H, Yu Q, et al
    Decreased Expression of MiR-138-5p by LncRNA H19 in Cervical Cancer Promotes Tumor Proliferation.
    Oncol Res. 2017 Aug 10. doi: 10.3727/096504017X15017209042610.
    PubMed     Text format     Abstract available


    Oncologist

  30. RAGAN KR, Buchanan Lunsford N, Lee Smith J, Saraiya M, et al
    Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya.
    Oncologist. 2017 Aug 10. pii: theoncologist.2017-0053.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  31. ZHAO HB, Zhang XF, Jia XL, Wang HB, et al
    Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells.
    Pathol Res Pract. 2017 Jul 26. pii: S0344-0338(16)30760.
    PubMed     Text format     Abstract available


    Patient Educ Couns

  32. KORFAGE IJ, de Kwaadsteniet EW, van Voorst A, Stiggelbout AM, et al
    Preferences for cervical cancer screening: The role of implicit associations.
    Patient Educ Couns. 2017 Jul 27. pii: S0738-3991(17)30463.
    PubMed     Text format     Abstract available


    PLoS One

  33. SMELOV V, Gheit T, Sundstrom K, Ploner A, et al
    Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study.
    PLoS One. 2016;11:e0156215.
    PubMed     Text format     Abstract available


    Toxicol Lett

  34. IIHOSHI H, Ishihara T, Kuroda S, Ishihara N, et al
    Aclarubicin, an anthracycline anti-cancer drug, fluorescently contrasts mitochondria and reduces the oxygen consumption rate in living human cells.
    Toxicol Lett. 2017;277:109-114.
    PubMed     Text format     Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  35. DENG YQ, Zhou XH, Jiang LL, Tang XJ, et al
    [Clinical significance of sigma1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:473-482.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: